Clinical Trials List
Protocol NumberHCB101-101
2023-03-19 - 2026-03-16
Phase I
Not yet recruiting3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- MING YAO 無
- 徐偉勛 無
- Shang-Ju Wu 無
- WEI-LI MA 無
- Jih-Hsiang Lee 無
- Wei-Wu Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tsu-Yi Chao 無
- 莊博雅 無
- HUI-WEN LIU 無
- TSU-YI CHAO 無
- Tsung-Ming Chen 無
- Yao-Yu Hsieh 無
- 黃金聲 無
- 蘇智銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
60 participants
